Market Overview

Sterne Agee CRT Initiates Coverage on Imprimis Pharmaceuticals at Buy, Announces $10.00 PT

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real time — before the crowd.

Click here to get FREE 14-day trial of Benzinga Pro today.

Latest Ratings for IMMY

DateFirmActionFromTo
Nov 2016Rodman & RenshawInitiates Coverage OnBuy
Jul 2015Sterne Agee CRTInitiates Coverage onBuy
Dec 2014Craig-HallumInitiates Coverage onBuy

View More Analyst Ratings for IMMY
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (IMMY)